Enlivex Therapeutics Ltd. (ENLV)
$0.25-10.71%Close
SELLCRISIS · day 88
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $4M
- Beta
- 1.42
- P/E (TTM)
- 0.00
- Short % float
- 0.59%
- Days to cover
- 1.0
- SI change
- +104.5%
- 1W
- -35.90%
- 1M
- -74.49%
- vs SPY 1W
- -37.06%
- vs SPY 1M
- -77.48%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ENLV?
- LOPJLB’s latest quantitative signal on Enlivex Therapeutics Ltd. (ENLV) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ENLV in?
- Enlivex Therapeutics Ltd. (ENLV) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Enlivex Therapeutics Ltd. (ENLV) do?
- Enlivex Therapeutics Ltd., established in 2005 and based in Nes Ziona, Israel, operates as a clinical-stage biotechnology firm dedicated to macrophage reprogramming immunotherapy. The company is currently advancing Allocetra, its flagship cell-based therapeutic. This treatment is undergoing Phase II clinical evaluation for its effectiveness in addressing organ dysfunction and failure that arise…